Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
37.00
0.00 (0.00%)
Oct 30, 2025, 4:00 PM EDT - Market closed
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $103.07 million as of October 31, 2025. Its market cap has increased by 444.12% in one year.
Market Cap
103.07M
Enterprise Value
81.32M
1-Year Change
444.12%
Ranking
Category
Stock Price
$37.00
Market Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has decreased from $245.32M to $103.07M, a decrease of -57.98%. That is a compound annual growth rate of -10.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 103.07M | 297.81% |
| Dec 31, 2024 | 25.91M | -15.83% |
| Dec 29, 2023 | 30.78M | -70.81% |
| Dec 30, 2022 | 105.47M | -38.35% |
| Dec 31, 2021 | 171.08M | -24.02% |
| Dec 31, 2020 | 225.18M | -35.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 740.63B |
| Johnson & Johnson | 451.62B |
| AbbVie | 401.66B |
| UnitedHealth Group | 319.05B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 218.55B |